Search research articles
Contact Us
Filters
Showing results (111-120 of 122) with videos related to
Page
of 13
Sort By:
Advances in Radiation Oncology
|
February 1, 2021
Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of <sup>18</sup>F-DCFPyL PET/CT Restaging
Wei Liu, Katherine Zukotynski, Louise Emmett, et al.
JAMA Oncology
|
March 16, 2018
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial
Jeff M Michalski, Jennifer Moughan, James Purdy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 16, 2019
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy
Wei Liu, Katherine Zukotynski, Louise Emmett, et al.
European Urology Oncology
|
February 4, 2025
Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials
Cristian Udovicich, Patrick Cheung, William Chu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 29, 2020
Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials
Yasir Alayed, Melanie Davidson, Stanley Liu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
Radiology
|
September 10, 2014
MR-guided prostate biopsy for planning of focal salvage after radiation therapy
Cynthia Ménard, Douglas Iupati, Julia Publicover, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2018
The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines
Albert J Chang, Sean McBride, Mira Keyes, et al.
JAMA Network Open
|
February 25, 2026
SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer
Cristian Udovicich, Patrick Cheung, William Chu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2023
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial
Daniel J Krauss, Theodore Karrison, Alvaro A Martinez, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 122) with videos related to
Sort By:
Page
of 13
Advances in Radiation Oncology
|
February 1, 2021
Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of <sup>18</sup>F-DCFPyL PET/CT Restaging
Wei Liu, Katherine Zukotynski, Louise Emmett, et al.
JAMA Oncology
|
March 16, 2018
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial
Jeff M Michalski, Jennifer Moughan, James Purdy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 16, 2019
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy
Wei Liu, Katherine Zukotynski, Louise Emmett, et al.
European Urology Oncology
|
February 4, 2025
Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials
Cristian Udovicich, Patrick Cheung, William Chu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 29, 2020
Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials
Yasir Alayed, Melanie Davidson, Stanley Liu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
Radiology
|
September 10, 2014
MR-guided prostate biopsy for planning of focal salvage after radiation therapy
Cynthia Ménard, Douglas Iupati, Julia Publicover, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2018
The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines
Albert J Chang, Sean McBride, Mira Keyes, et al.
JAMA Network Open
|
February 25, 2026
SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer
Cristian Udovicich, Patrick Cheung, William Chu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2023
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial
Daniel J Krauss, Theodore Karrison, Alvaro A Martinez, et al.
Page
of 13